RecruitingNot ApplicableNCT07777367

Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Chronic Lung Diseases

Exercise Performance on Ambient Air vs. Commonly Prescribed Nasal Low Flow Oxygen Therapy in Patients With Exercise Induced Desaturation Due to Pulmonary Disease

Sponsor

Silvia Ulrich Somaini

Enrollment

40 participants

Start Date

Oct 1, 2026

Study Type

INTERVENTIONAL

Conditions

Pulmonary Vascular Disease Pulmonary Arterial Hypertension PAH Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Summary

The investigators aim to study the effect of liquid oxygen therapy (4l/min, nasal) )in Swiss residents with pulmonary vascular diseases (PVD) defined as pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 6-minute walk distance (6MWD) test on ambient conditions and 6-minute walk distance (6MWD) test with supplemental oxygen (LOX) for people with chronic thromboembolic pulmonary hypertension (cteph), pulmonary arterial hypertension pah, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHER6-minute walk distance (6MWD) test on ambient conditions

6-minute walk distance (6MWD) test will be performed on ambient air according to clinical standards

OTHER6-minute walk distance (6MWD) test with supplemental oxygen (LOX)

6-minute walk test(6MWT) test will be performed according to clinical standards with supplemental liquid oxygen therapy (LOX, approximately 4l/min, nasal)

Locations(1)

University Hospital Zurich

Zurich, Canton of Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07777367

Related Trials

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

NCT0731859724 locations

Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD)

NCT07777445

Contrast Echocardiography During Exercise to Assess Pulmonary Blood Volume

NCT061950591 location

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

NCT0717503819 locations

Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial Hypertension

NCT077139141 location